ArticleClinical and experimental hepatology2025
Efficacy of zinc and lactulose vs. lactulose monotherapy in improving cognitive function and serum ammonia levels in cirrhotic patients with minimal hepatic encephalopathy.
Article in Clinical and experimental hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim of the study: Minimal hepatic encephalopathy (MHE) is a common yet frequently underdiagnosed complication of liver cirrhosis, characterized by subtle cognitive impairment and elevated serum ammonia levels. This study aimed to compare the effectiveness of zinc supplementation combined with lactulose versus lactulose monotherapy in improving cognitive function and lowering serum ammonia levels in cirrhotic patients with MHE. Material and methods: This prospective cohort study was conducted on 148 cirrhotic patients, aged 18-60 years, clustered into two groups ( Results: The two groups were comparable at baseline. After 12 weeks, significant improvements were observed in PHES scores in both groups ( Conclusions: Adding zinc to standard lactulose therapy significantly improves cognitive recovery and lowers serum ammonia in cirrhotic patients with MHE. This combination accelerates clinical improvement without added side effects, supporting zinc supplementation as an effective adjunct in managing early-stage hepatic encephalopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.